asset sale News
Most Popular asset sale Story
Merck acquires biosimilars in $130M pact
Merck signaled its clear intent to get aggressive about the biosimilar business with this morning's announcement that the pharma giant is buying Insmed's portfolio of follow-on biologics for $130 Read more...
Latest Headlines
- November 9, 2009
- October 2, 2009
- September 28, 2009
- September 24, 2009
- September 11, 2009
- September 9, 2009
- July 30, 2009
- May 12, 2009
- April 3, 2009
- February 24, 2009
- February 23, 2009
- February 18, 2009
- February 12, 2009
- February 5, 2009
- February 4, 2009
- January 28, 2009
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline
